ERG |
VCaP (prostate carcinoma) |
NT |
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
siERG |
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
regular medium |
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
LNCaP (prostate carcinoma) |
regular medium |
Permissive
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
mutational form of the peptide (*ERG inhibitory peptidomimetics*) |
Permissive
Robust
|
Homo sapiens |
GSE58939
...
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
functional form of the peptide (*ERG inhibitory peptidomimetics*) |
Permissive
Robust
|
Homo sapiens |
GSE58939
...
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
mutated ERG |
Permissive
|
Homo sapiens |
GSE73616
...
|
MA0474.2
|
ERG |
HAEC (human aortic endothelial cells) |
TNFa, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0474.2
|
ERG |
HAEC (human aortic endothelial cells) |
control, 4h |
Permissive
Robust
|
Homo sapiens |
GSE89970
...
|
MA0474.2
|
ERG |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 0 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0474.2
|
ERG |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 1 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0474.2
|
ERG |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 12 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
Infection: retrovirus expressing FLAG-ERG Treatment: nearly confluent 150 mm dishes were treated with 1% formaldehyde, and harvested in Farnham lysis buffer and a crude nuclear pellet collected after centrifugation |
Permissive
Robust
|
Homo sapiens |
GSE114241
...
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
Treatment: no Genotype: expressing point-mutant(S96E) of ERF |
Permissive
|
Homo sapiens |
GSE86232
...
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
Treatment: no Genotype: expressing point-mutant(S96E) of ERF |
Permissive
Robust
|
Homo sapiens |
GSE86232
...
|
MA0474.2
|
ERG |
prostate cancer |
Strain:: 129/C57Bl6; Treatment: CRISPR-AR; Genotype: Pten-/- Rosa26-Tmprss2-ERG, AR knockout; |
Permissive
Robust
|
Mus musculus |
GSE112414
...
|
MA0474.2
|
ERG |
prostate cancer |
Strain:129/C57Bl6; Treatment: CRISPR-ERG; Genotype: Pten-/- Rosa26-Tmprss2-ERG, ERG knockout; |
Permissive
|
Mus musculus |
GSE112414
...
|
MA0474.2
|
ERG |
CD34+ cells |
NR29 |
Permissive
|
Homo sapiens |
GSE23730
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
FLAG |
Permissive
Robust
|
Homo sapiens |
GSE29808
|
MA0474.2
|
ERG |
prostate cancer |
|
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
prostate cancer |
|
Permissive
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
metastatic prostate cancer tissue |
|
Permissive
Robust
|
Homo sapiens |
GSE14092
...
|
MA0474.2
|
ERG |
prostate |
|
Permissive
Robust
|
Mus musculus |
GSE47119
...
|
MA0474.2
|
ERG |
prostate |
|
Permissive
Robust
|
Mus musculus |
GSE47119
...
|
MA0474.2
|
ERG |
prostate |
|
Permissive
Robust
|
Mus musculus |
GSE47119
...
|
MA0474.2
|
ERG |
prostate |
|
Permissive
|
Mus musculus |
GSE47119
...
|
MA0474.2
|
ERG |
spleen |
|
Permissive
Robust
|
Mus musculus |
GSE46554
...
|
MA0474.2
|
ERG |
spleen |
|
Permissive
Robust
|
Mus musculus |
GSE46554
...
|
MA0474.2
|
ERG |
CD34+ hematopoietic stem cells |
|
Permissive
Robust
|
Homo sapiens |
GSE45144
...
|
MA0474.2
|
ERG |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE48085
...
|
MA0474.2
|
ERG |
acute myeloid leukemia |
|
Permissive
Robust
|
Mus musculus |
GSE66122
...
|
MA0474.2
|
ERG |
416B (hematopoietic precursor cells) |
|
Permissive
Robust
|
Mus musculus |
GSE69776
...
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE73616
...
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE73616
...
|
MA0474.2
|
ERG |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE76464
...
|
MA0474.2
|
ERG |
Hoxb8-FL |
|
Permissive
Robust
|
Mus musculus |
GSE84328
...
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE98809
...
|
MA0474.2
|
ERG |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE109695
...
|
MA0474.2
|
ERG |
|
|
Permissive
|
Homo sapiens |
GSE23730
|
MA0474.2
|
ERG |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE23730
|
MA0474.2
|
ERG |
SKNO-1 (acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE23730
|
MA0474.2
|
ERG |
RWPE1 (prostate epithelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE37752
|
MA0474.2
|
ERG |
ME-1 (acute myeloid leukemia ) |
|
Permissive
Robust
|
Homo sapiens |
GSE46044
|
MA0474.2
|
ERG |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE49091
|
MA0474.2
|
ERG |
|
|
Permissive
|
Homo sapiens |
GSE55062
|
MA0474.2
|
ERG |
|
|
Permissive
|
Homo sapiens |
GSE55062
|
MA0474.2
|
ERG |
K562 (myelogenous leukemia) |
DOX |
Permissive
|
Homo sapiens |
GSE23730
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
DHAT_18H |
Permissive
Robust
|
Homo sapiens |
GSE28950
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
DHAT_2H |
Permissive
Robust
|
Homo sapiens |
GSE28950
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
ETOH |
Permissive
|
Homo sapiens |
GSE49091
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
R1881 |
Permissive
|
Homo sapiens |
GSE49091
|
MA0474.2
|
ERG |
TSU-1621-MT (adult acute myeloid leukemia) |
ATRA |
Permissive
Robust
|
Homo sapiens |
GSE60477
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
DHT |
Permissive
Robust
|
Homo sapiens |
GSE79128
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
SH1_DHT |
Permissive
Robust
|
Homo sapiens |
GSE79128
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
SH2_DHT |
Permissive
Robust
|
Homo sapiens |
GSE79128
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
SH3_DHT |
Permissive
Robust
|
Homo sapiens |
GSE79128
|
MA0474.2
|
ERG |
K562 (myelogenous leukemia) |
|
Permissive
|
Homo sapiens |
GSE23730
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE28950
|
MA0474.2
|
ERG |
VCaP (prostate carcinoma) |
|
Permissive
|
Homo sapiens |
GSE49091
|
MA0474.2
|
ERG |
TSU-1621-MT (adult acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE60477
|
MA0474.2
|